Published in Cancer Res on April 01, 1996
Retinoids: present role and future potential. Br J Cancer (1999) 1.28
Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol (1997) 1.09
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro. Br J Cancer (1999) 0.79
Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles. Int J Nanomedicine (2012) 0.77
Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature (1992) 4.44
A novel progressive spongiform encephalopathy in cattle. Vet Rec (1987) 4.39
How lac repressor binds to DNA. Nature (1972) 3.72
Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature (1992) 3.39
A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature (1988) 3.33
"Second" and "third operator" of the lac operon: an investigation of their role in the regulatory mechanism. J Mol Biol (1979) 2.56
Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity. Nature (1989) 2.23
A novel thyroid hormone receptor encoded by a cDNA clone from a human testis library. Science (1987) 2.21
Primary parenteral transmission of bovine spongiform encephalopathy to the pig. Vet Rec (1990) 2.19
Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization. Ann Neurol (1982) 2.12
Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec (1998) 2.05
COUP orphan receptors are negative regulators of retinoic acid response pathways. Mol Cell Biol (1992) 1.94
Towards a differential polymerase chain reaction test for Chlamydia psittaci. Vet Rec (1991) 1.94
An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem (1996) 1.92
Retinoids selective for retinoid X receptor response pathways. Science (1992) 1.91
Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J Gen Virol (1991) 1.88
A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol (1994) 1.86
Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp. J Virol (2001) 1.86
Specific binding of the glucocorticoid-receptor complex to the mouse mammary tumor proviral promoter region. Cell (1982) 1.75
Molecular screening of sheep for bovine spongiform encephalopathy. Neurosci Lett (1998) 1.74
Translational regulation: identification of the site on bacteriophage T4 rIIB mRNA recognized by the regA gene function. Proc Natl Acad Sci U S A (1981) 1.63
Cognitive mechanisms, specificity and neural underpinnings of visuospatial peaks in autism. Brain (2006) 1.62
Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins. Infect Immun (1985) 1.55
Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature (1988) 1.54
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine. Vaccine (2000) 1.51
Repressors. Adv Protein Chem (1976) 1.51
Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation. New Biol (1991) 1.44
A retinoic acid receptor-specific element controls the retinoic acid receptor-beta promoter. Mol Endocrinol (1990) 1.43
Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. Vet Microbiol (1988) 1.43
Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol (1991) 1.41
A methodology based on NMR spectroscopy for the forensic analysis of condoms. J Forensic Sci (2001) 1.38
Three-dimensional imaging of magnetic domains. Nat Commun (2010) 1.38
Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer (1997) 1.33
A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (1994) 1.31
Characteristics of tight binding repressors of the lac operon. J Mol Biol (1981) 1.29
Genetic analysis of the active sites of lac repressor. Genetics (1974) 1.27
DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J (1984) 1.27
Translational repression: biological activity of plasmid-encoded bacteriophage T4 RegA protein. J Mol Biol (1987) 1.26
Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. Mol Endocrinol (1993) 1.24
Design and utility of oligonucleotide gene probes for fungal polyketide synthases. Chem Biol (2001) 1.22
Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching. Mol Cell Biol (1993) 1.22
Novel polymorphisms in the caprine PrP gene: a codon 142 mutation associated with scrapie incubation period. J Gen Virol (1996) 1.21
Asymmetry of gait initiation in hemiparetic stroke subjects. Arch Phys Med Rehabil (1997) 1.21
The ribosomal intergenic spacer region: a target for the PCR based diagnosis of tuberculosis. Tuber Lung Dis (1994) 1.18
Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec (1994) 1.18
Nuclear retinoic acid receptors: cloning, analysis, and function. Methods Enzymol (1990) 1.17
General features of steroid resistance on lymphoid cell lines. Mol Cell Endocrinol (1978) 1.16
The human estrogen receptor has transcriptional activator and repressor functions in the absence of ligand. New Biol (1990) 1.16
RAR gamma 2 expression is regulated through a retinoic acid response element embedded in Sp1 sites. Mol Cell Biol (1992) 1.15
Early increase in histone H1(0) mRNA during differentiation of F9 cells to parietal endoderm. EMBO J (1988) 1.15
Immunopurification of functional Asp-ase (natural killer cell granzyme B) using a monoclonal antibody. Biochem Biophys Res Commun (1993) 1.14
Antagonism between retinoic acid receptors. Mol Cell Biol (1991) 1.14
Genetic map of the lactose repressor gene (i) of Escherichia coli. Genetics (1972) 1.13
lac Repressor-operator interaction. Analysis of the X86 repressor mutant. J Mol Biol (1976) 1.13
Identification of two new bacteriophage T4 genes that may have roles in transcription and DNA replication. J Virol (1987) 1.11
Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle. J Gen Virol (2007) 1.10
Genetic analysis of capsular status of meningococcal carrier isolates. Epidemiol Infect (2003) 1.09
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J Biol Chem (1996) 1.07
Global survey of serological evidence of caprine arthritis-encephalitis virus infection. Vet Rec (1984) 1.07
Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor. Mol Cell Biol (1994) 1.06
Correlation of glucocorticoid receptor binding sites on MMTV proviral DNA with hormone inducible transcription. Science (1983) 1.06
Relationships between chemical changes and histological damage in the brains of scrapie affected mice. J Comp Pathol (1967) 1.05
Transmission of bovine spongiform encephalopathy to mice. Vet Rec (1988) 1.05
Frequencies of PrP genotypes in 38 breeds of sheep sampled in the National Scrapie Plan for Great Britain. Vet Rec (2005) 1.05
Effect of DNA denaturants on the lac repressor-operator interaction. Biochim Biophys Acta (1978) 1.05
Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol (1997) 1.04
A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer. Biochem Biophys Res Commun (1992) 1.03
Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. Mol Endocrinol (1991) 1.02
Heterodimeric receptor complexes determine 3,5,3'-triiodothyronine and retinoid signaling specificities. Mol Endocrinol (1992) 1.02
TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Mol Endocrinol (1995) 1.01
Comparison of serological tests used in three state veterinary laboratories to identify maedi-visna virus infection. Vet Rec (1982) 1.01
Antigenic and morphological differentiation of placental and intestinal isolates of Chlamydia psittaci of ovine origin. Vet Microbiol (1992) 1.01
Organization and expression of H1 histone and H1 replacement histone genes. J Cell Biochem (1994) 1.01
Retinoic acid affects the expression of nuclear retinoic acid receptors in tissues of retinol-deficient rats. Proc Natl Acad Sci U S A (1991) 1.01
Umbilical cord circumference at birth. Am J Dis Child (1989) 1.00
Interaction of glucocorticoid receptors from lymphoid cell lines with their nuclear acceptor sites. Mol Cell Endocrinol (1978) 0.99
Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat Med (1997) 0.99
Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. J Biol Chem (1994) 0.99
DNA bending by retinoid X receptor-containing retinoid and thyroid hormone receptor complexes. Mol Cell Biol (1993) 0.98
Maedi/visna: a review. Vet Rec (1980) 0.97
Improved expression of human interleukin-2 in high-cell-density fermentor cultures of Escherichia coli K-12 by a phosphotransacetylase mutant. Appl Environ Microbiol (1990) 0.97
Genetic mapping of the amino-terminal domain of bacteriophage T4 DNA polymerase. Genetics (1987) 0.97
Immunoperoxidase detection of chlamydia ovis in experimentally-infected cell culture. Br Vet J (1981) 0.97
RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br J Pharmacol (1999) 0.97
Mutation testing in Treacher Collins Syndrome. J Orthod (2002) 0.96
Pathogenesis of maedi-visna. Vet Rec (1987) 0.96
Factors affecting the frequency infection in renal transplant recipients. Arch Intern Med (1976) 0.96
Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem (1995) 0.95
Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem (1994) 0.95
Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer (1999) 0.95
Hetero- and homodimeric receptors in thyroid hormone and vitamin A action. Receptor (1993) 0.94
Genomic organization of the retinoic acid receptor gamma gene. Nucleic Acids Res (1991) 0.93
4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone, a prodrug of mebendazole. Eur J Drug Metab Pharmacokinet (1984) 0.93
Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. Cambridge Neuropsychological Test Automated Battery. J Hypertens (1999) 0.93
Multiple cases of maedi and visna in a flock in East Anglia. Vet Rec (1995) 0.93
Novel properties of the protein kinase CK2-site-regulated nuclear- localization sequence of the interferon-induced nuclear factor IFI 16. Biochem J (2001) 0.93
A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res (1994) 0.92
An evolutionary conserved COUP-TF binding element in a neural-specific gene and COUP-TF expression patterns support a major role for COUP-TF in neural development. Mol Endocrinol (1994) 0.92